Skip to main content
Atrás
Watch Compare

Elicio Therapeutics, Inc.

Calidad de datos: 83%
ELTX
Nasdaq Manufacturing Chemicals
$10.28
▲ $0.15 (1.48%)
Cap. Mercado: 189.11 M
Precio
$10.28
Cap. Mercado
189.11 M
Rango del Día
$10.02 — $10.89
Rango de 52 Semanas
$4.61 — $14.93
Volumen
71,777
Apertura $10.07
Promedio 50D / 200D
$10.18
1.00% above
Promedio 50D / 200D
$9.56
7.48% above

Quick Summary

Puntos Clave

Debt/Equity of 2.55 — high leverage
Negative free cash flow of -36.97 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-1400.74%
Below sector avg (-53.41%)
ROIC-144.02%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
2.55
Above sector avg (0.31)
Current Ratio3.29
Interest Coverage-33.29

Valoración

PE (TTM)
-4.78
Below sector avg (-1.48)
P/B Ratio49.56
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -4.8 -1.5
P/B 49.6 1.6
ROE % -1400.7 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E 2.6 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -39.57 M
ROE -1400.74% ROA -136.90%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -36.97 M
ROIC -144.02% FCF Growth (3Y) N/A
Safety
Debt / Equity 2.55 Current Ratio 3.29
Interest Coverage -33.29 Asset Turnover N/A
Working Capital 14.95 M Tangible Book Value 3.82 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.78 Forward P/E N/A
P/B Ratio 49.56 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -19.55%
Market Cap 189.11 M Enterprise Value 178.22 M
Per Share
EPS (Diluted TTM) -2.58 Revenue / Share N/A
FCF / Share -2.01 OCF / Share -2.01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 93.42%
SBC-Adj. FCF -39.21 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — 2.30 M 28.31 M
Net Income -39.57 M -51.90 M -35.20 M -38.81 M -54.57 M
EPS (Diluted) -2.58 -4.25 -6.96 -1.29 -1.93
Gross Profit — — — — —
Operating Income -37.71 M -44.99 M -35.75 M -39.62 M -39.31 M
EBITDA — — — — —
R&D Expenses 24.90 M 33.66 M 23.85 M 18.10 M 48.70 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 1.13 M 455,000.0 1.06 M 805,000.0 -1.85 M
Income Tax 0.0 0.0 0.0 11,000.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 25.86 M 28.18 M 27.15 M 52.79 M 96.51 M
Total Liabilities 24.23 M 39.49 M 15.77 M 9.02 M 15.01 M
Shareholders' Equity 1.64 M -11.31 M 11.37 M 43.77 M 81.51 M
Total Debt 10.00 M — — — 0.0
Cash & Equivalents 18.56 M 17.62 M 12.89 M 50.49 M 88.76 M
Current Assets 19.31 M 20.69 M 16.35 M 51.43 M 91.25 M
Current Liabilities 8.11 M 11.52 M 9.77 M 6.37 M 11.30 M